BackPfizer Overview

Pfizer Minority Interest

Latest minority interest for PFE: $300M.

Get informed when a big investor buys or sells

+ Follow
Minority Interest
$302.00M
↓ 4.73% YoYΔ $-15.00M vs prior year quarter

Peer average / median

Loading

Pfizer Minority Interest History

Loading

Pfizer vs. peers: Minority Interest Comparison

Loading

Pfizer Minority Interest Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Pfizer (PFE) FAQ

As of the most recent data (June 2026), PFE shows a minority interest of $300M. That compares with $320M in the prior-year period — down 4.7% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, PFE's minority interest is now $300M (was $320M) — a 4.7% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Pfizer is outperforming or lagging.

Tracking PFE's minority interest over time shows whether Pfizer is scaling, shrinking, or reshaping that part of the business. The current reading is $300M That compares with $320M in the prior-year period — down 4.7% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this minority interest page, Stockcircle has Pfizer's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect minority interest (currently $300M) with ownership activity and broader fundamentals.

Pfizer's minority interest is $300M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.